Ceramides and renal dysfunction in coronary artery disease: Promising biomarkers awaiting validation
Journal of Clinical Lipidology · 2026-02 · 20 (2) · 467-468
DOI: 10.1016/j.jacl.2025.09.019 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Clinical Lipidology, 2026-02. Verfasst von Muhammet Cihat Çelik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hitit University Erol Olçok Education and Research Hospital, Corum, Turkey (Drs Çelik and Aker). Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Cardiology, Hitit University Erol Olçok Education and Research Hospital, Corum, Turkey (Drs Çelik and Aker).
- Faculty of Medicine, Department of Cardiology, Hitit University, Corum, Turkey (Dr Kalçık). Electronic address: macitkalcik@yahoo.com.
Zitieren
APA
Çelik, M. C., Aker, M., & Kalçık, M. (2026). Ceramides and renal dysfunction in coronary artery disease: Promising biomarkers awaiting validation. Journal of Clinical Lipidology, 20(2), 467-468. https://doi.org/10.1016/j.jacl.2025.09.019
Vancouver
Çelik MC, Aker M, Kalçık M. Ceramides and renal dysfunction in coronary artery disease: Promising biomarkers awaiting validation. Journal of Clinical Lipidology. 2026;20(2):467-468. doi:10.1016/j.jacl.2025.09.019
BibTeX
@article{elik2026,
author = {Çelik, Muhammet Cihat and Aker, Mücahit and Kalçık, Macit},
title = {Ceramides and renal dysfunction in coronary artery disease: Promising biomarkers awaiting validation},
journal = {Journal of Clinical Lipidology},
year = {2026},
volume = {20},
number = {2},
pages = {467--468},
doi = {10.1016/j.jacl.2025.09.019}
}
EUVIMED